David Byrne - Sonic Healthcare Chief Laboratory
| SHL Stock | 28.68 0.72 2.58% |
Insider
David Byrne is Chief Laboratory of Sonic Healthcare
| Age | 65 |
| Address | Grosvenor Place, Sydney, NSW, Australia, 2000 |
| Phone | 61 2 9855 5444 |
| Web | https://www.sonichealthcare.com |
Sonic Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.0388 % which means that it generated a profit of $0.0388 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.068 %, meaning that it generated $0.068 on every $100 dollars invested by stockholders. Sonic Healthcare's management efficiency ratios could be used to measure how well Sonic Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sonic Healthcare's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 15.6 B in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 44.6 M in 2024.Similar Executives
| Found 4 records | INSIDER Age | ||
| Donald Tremblay | Champion Iron | N/A | |
| David Eng | Champion Iron | N/A | |
| Philip Mackey | Champion Iron | 66 | |
| Alexandre Eng | Champion Iron | N/A | |
Management Performance
| Return On Equity | 0.068 | ||||
| Return On Asset | 0.0388 |
Sonic Healthcare Leadership Team
Elected by the shareholders, the Sonic Healthcare's board of directors comprises two types of representatives: Sonic Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonic. The board's role is to monitor Sonic Healthcare's management team and ensure that shareholders' interests are well served. Sonic Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonic Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Fairy, Global Officer | ||
| Julian Adler, Chief Radiology | ||
| Mrs Schottdorf, Chief Group | ||
| FAICD FRCPA, MD CEO | ||
| BCom FACID, CFO Director | ||
| BEc CA, Deputy Sec | ||
| David Byrne, Chief Laboratory | ||
| Prashan Kulasekera, Assistant Secretary | ||
| Peter Savage, Chief Officer | ||
| FACID FAICD, MD CEO |
Sonic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sonic Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.068 | ||||
| Return On Asset | 0.0388 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 17.65 B | ||||
| Shares Outstanding | 480.4 M | ||||
| Shares Owned By Insiders | 5.30 % | ||||
| Shares Owned By Institutions | 42.67 % | ||||
| Price To Book | 1.74 X | ||||
| Price To Sales | 1.52 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sonic Stock Analysis
When running Sonic Healthcare's price analysis, check to measure Sonic Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonic Healthcare is operating at the current time. Most of Sonic Healthcare's value examination focuses on studying past and present price action to predict the probability of Sonic Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonic Healthcare's price. Additionally, you may evaluate how the addition of Sonic Healthcare to your portfolios can decrease your overall portfolio volatility.